Master Protocol of Sotorasib (AMG 510) in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 101)
20190135
Phase 1 other active
Quick answer
Master Protocol of Sotorasib (AMG 510) in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 101) for Advanced Solid Tumors Kirsten Rat Sarcoma (KRAS) pG12C Mutation is a Phase 1 program (other) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Advanced Solid Tumors Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Phase
- Phase 1
- Modality
- other
- Status
- active